Thank you, Mr. Chair.
Thank you to the witnesses. We're doing a very technical study. We really appreciate your giving your technical expertise.
I'd like to draw my questions over to Dr. Chandrasekera around animal testing. Recently I met with the Guelph Humane Society in their new facility. We moved quickly from talking about the new facility and the animal care that's going on there to the topic of CEPA and the provisions around animal testing.
We also have the University of Guelph, which is doing a lot of work around animals—for testing, including using animals for testing cancer drugs. Drugs are being developed for ovarian cancer and other cancers at the University of Guelph.
I'd like to focus on these new approach methods and what role CEPA can play in transitioning us from the dated practices around animal testing and towards the more innovative technological solutions that are out there.